** Shares of Aroa Biosurgery Ltd ARX.AX rise as much as
5.6% to A$0.85, their highest since Aug 16
** Regenerative medicine co raises FY23 total revenue
forecast by 39-43% on a constant currency basis to between NZ$62
mln ($35.34 mln) and NZ$64 mln urn:newsml:reuters.com:*:nASX7jTMwH
** Says unaudited product revenue grew 44% to NZ$28.8 mln
** Stock posts its biggest intraday pct gain since Sept 30
** More than 305,828 shares change hands, vs the 30-day
average volume of 165,017 shares
** Stock down 21.1% this year as of last close
($1 = 1.7544 New Zealand dollars)
(Reporting by Poonam Behura in Bengaluru)
((Poonam.Behura@thomsonreuters.com;))